OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
My lab focuses on human tissue-resident T cells and their interactions in order to harness them for novel immunotherapeutic approaches, in particular pan-coronavirus prophylactic vaccines and therapeutic vaccines for hepatitis B and hepatocellular carcinoma. I will discuss our recent work on stromal-mediated instruction of liver-resident T cells by myeloid cells (Pallett et al, Nature 2023). I will also show data on liver-resident NK cell regulation of hepatitis B-specific T cells and immunotherapeutic strategies to overcome this (Diniz et al, Sci Trans Med 2023 and unpublished).
